Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Drug index / Prescription / Quetiapine
Prescription

Quetiapine

2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol

Quetiapine (Seroquel) is a second-generation antipsychotic for schizophrenia, bipolar disorder, and depression. It is not a controlled substance, but its heavy sedation drives off-label misuse as a sleep aid — a reputation that hides real dangers: QT-prolongation and heart-rhythm risk, metabolic and blood-pressure effects, and compounded respiratory depression when mixed with other CNS depressants.

Overview

Quetiapine is a second-generation, or atypical, antipsychotic, sold most widely under the brand name Seroquel, approved to treat schizophrenia, bipolar disorder and, as an adjunct, major depressive disorder. It is not a classic recreational drug and is not a controlled substance, but it is heavily sedating and is sometimes misused, often at low doses as a sleep aid and sometimes in institutional or polydrug settings, which is why it appears in a harm-reduction context. Its street reputation as a harmless sleeping pill understates its cardiac and metabolic risks.

Source: MedlinePlus; DailyMed (FDA label); StatPearls (NCBI Bookshelf)

Chemistry & mechanism of action

Quetiapine acts on multiple neurotransmitter systems, blocking dopamine D2 receptors, the basis of its antipsychotic effect, and prominently serotonin and histamine H1 receptors. Its strong antihistamine action is largely responsible for the heavy sedation and grogginess that drive its non-medical use as a sleep aid. It also blocks certain adrenergic receptors, which contributes to drops in blood pressure. This broad receptor activity explains both its therapeutic effects and its wide side-effect profile.

Source: StatPearls (NCBI Bookshelf); MedlinePlus

Effects

The most noticeable effects are strong sedation, drowsiness and calm, along with dizziness and dry mouth. Because it lowers blood pressure, standing up can cause lightheadedness or fainting, and it can affect coordination. Unlike many misused drugs it does not typically produce euphoria; the appeal is sedation. Even a single low dose can leave people heavily sedated and impaired well into the next day.

Source: MedlinePlus; DailyMed (FDA label)

Risks & harms

Although quetiapine is not a controlled substance, it is not benign. Its labeling carries warnings about a range of serious effects: it can prolong the heart's QT interval and, particularly in overdose or when combined with other QT-prolonging drugs, contribute to dangerous heart-rhythm disturbances. Atypical antipsychotics as a class raise the risk of high blood sugar, diabetes and significant weight gain with ongoing use, and can cause dangerous drops in blood pressure and falls. Rare but serious reactions include neuroleptic malignant syndrome, a life-threatening reaction with high fever and rigidity, and low white-blood-cell counts. Because quetiapine is a strong sedative, combining it with other central nervous system depressants such as alcohol, opioids or benzodiazepines compounds sedation and respiratory depression and can be dangerous. Its calming reputation masks these risks. Stopping abruptly after regular use can cause withdrawal-like effects such as nausea, insomnia and rebound symptoms, so it is generally tapered under medical guidance. Overdose can cause profound sedation, low blood pressure and heart-rhythm problems and warrants urgent care. If someone is unresponsive, having a seizure, or showing an irregular heartbeat, call 911; Poison Control at 1-800-222-1222 can advise on suspected overdoses. This page has not yet been medically reviewed.

Source: DailyMed (FDA label); StatPearls (NCBI Bookshelf); MedlinePlus

Images

Visual references coming soon.

If it’s too intense

If an experience becomes overwhelming, the goal is to stay safe and let it pass, most difficult experiences ease as the drug wears off.

  • Get to a calm, safe space with someone you trust who is sober and can stay with you.
  • Cool down if you’re overheating, move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
  • Sip water to thirst, but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
  • Slow your breathing, long, slow exhales help settle a racing heart and anxiety.
  • A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
  • Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
Call 911 (or Poison Control, 1-800-222-1222) right away for chest pain, a very high body temperature, a seizure, unconsciousness, or severe confusion. These are medical emergencies, not something to wait out.

Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft, not yet medically reviewed.

Forensic dossier

Draft · every field is source-cited or marked “Unknown, pending review”

Identity

IUPAC name
2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanolPubChem PUG-REST ↗ · retrieved 2026-06-18
SMILES
C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42PubChem PUG-REST ↗ · retrieved 2026-06-18
InChIKey
URKOMYMAXPYINW-UHFFFAOYSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
Synonyms / aliases
seroquel, quetiapina, Norsic, quetiapinum, Quetiapine extended release, Seroquel XL, Tenprolide xl, Biquelle xl, Brancico xl, Mintreleq xl, Seotiapim xlPubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18

Composition

Composition
N/A — single compound (see Identity)

Physical / pill characteristics

Dosage form
3 DOSAGE FORMS & STRENGTHS Quetiapine Tablets, USP 25 mg are Peach coloured, film coated, round shape, biconvex tablets, debossed with "262" on other side and popenFDA drug label ↗ · retrieved 2026-06-18
Shape
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Color
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Imprint
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Score
Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)

Scheduling & legal status

US schedule
Unknown — pending review
International
Unknown, pending review

Effects, risks & interactions

Effects
Quetiapine is an atypical antipsychotic used for schizophrenia and bipolar disorder and, off-label, for sleep and anxiety; it acts on a range of receptors (dopamine, serotonin, histamine and others). It is not a recreational euphoriant or stimulant — its most prominent felt effect is strong sedation, especially at lower doses where its antihistamine action dominates, which is why it is misused as a sleep aid and in some institutional settings rather than for a "high." Any sought-after effect is sedation, not intoxication.PubChem CID 5002 + DailyMed Seroquel ↗ · retrieved 2026-06-18
Risks
Quetiapine's risks are those of a sedating antipsychotic rather than a party drug: pronounced drowsiness and next-day sedation, dizziness and a drop in blood pressure on standing (a falls risk), and — with regular use — significant metabolic effects including weight gain and raised blood sugar and lipids. It can prolong the heart's QT interval, and, as with all antipsychotics, it carries rare but serious risks (neuroleptic malignant syndrome; increased mortality in elderly people with dementia-related psychosis). In overdose it causes deep sedation, and that danger grows when it is combined with other CNS depressants.PubChem CID 5002 + DailyMed Seroquel ↗ · retrieved 2026-06-18
Interactions
Quetiapine is metabolised by the liver enzyme CYP3A4, so strong inhibitors of it (some antifungals and antibiotics) sharply raise quetiapine levels — the label advises a large dose reduction — while strong inducers lower them and can require a dose increase. Combined with other CNS depressants (alcohol, sedatives, opioids) its sedation is additive, and drugs that prolong the QT interval add to its cardiac risk.DailyMed Seroquel §7 ↗ · retrieved 2026-06-18

Pill catalog

Rx/OTC variants · openFDA + DailyMed (public domain) · draft, pending review

This drug comes in 327different versions. Make sure you’re looking at the right one, use the search above to find your exact pill by imprint, color, or shape.

Showing 24 of 327 variants

?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 300 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, FILM COATED
Labeler
A-S Medication Solutions
NDC
50090-3983 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 100 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, FILM COATED
Labeler
Bryant Ranch Prepack
NDC
63629-4776 ↗ · 2026-06-18
260
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 200 mg/1
Imprint
260
Color
WHITE
Shape
ROUND
Form
TABLET, FILM COATED
Labeler
Ascend Laboratories, LLC
NDC
67877-246 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 300 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, FILM COATED
Labeler
NuCare Pharmaceuticals,Inc.
NDC
68071-1669 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 100 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, FILM COATED
Labeler
REMEDYREPACK INC.
NDC
70518-3429 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 400 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, FILM COATED, EXTENDED RELEASE
Labeler
Major Pharmaceuticals
NDC
0904-6805 ↗ · 2026-06-18
353
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 150 mg/1
Imprint
353
Color
YELLOW
Shape
ROUND
Form
TABLET, FILM COATED
Labeler
Ascend Laboratories, LLC
NDC
67877-245 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 400 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
American Health Packaging
NDC
60687-382 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 300 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, FILM COATED
Labeler
Bryant Ranch Prepack
NDC
71335-0772 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 25 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
: Preferred Pharmaceuticals Inc.
NDC
68788-8764 ↗ · 2026-06-18
XR 300
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 300 mg/1
Imprint
XR 300
Color
YELLOW
Shape
CAPSULE
Form
TABLET, EXTENDED RELEASE
Labeler
AstraZeneca Pharmaceuticals LP
NDC
0310-0283 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 150 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, FILM COATED, EXTENDED RELEASE
Labeler
Direct_rx
NDC
72189-586 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 400 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, EXTENDED RELEASE
Labeler
Novast Laboratories, Ltd.
NDC
34908-639 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 150 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, EXTENDED RELEASE
Labeler
Novast Laboratories, Ltd.
NDC
34908-636 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 200 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, EXTENDED RELEASE
Labeler
Novast Laboratories, Ltd.
NDC
34908-637 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 150 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, FILM COATED, EXTENDED RELEASE
Labeler
Major Pharmaceuticals
NDC
0904-6802 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 400 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, FILM COATED
Labeler
REMEDYREPACK INC.
NDC
70518-3933 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 300 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, EXTENDED RELEASE
Labeler
Novast Laboratories, Ltd.
NDC
34908-638 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 300 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET, FILM COATED
Labeler
Bryant Ranch Prepack
NDC
71335-1709 ↗ · 2026-06-18
380
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 50 mg/1
Imprint
380
Color
pink
Shape
capsule
Form
TABLET, FILM COATED, EXTENDED RELEASE
Labeler
ACI Healthcare USA, Inc.
NDC
71093-135 ↗ · 2026-06-18
?
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 50 mg/1
Imprint
Unknown — pending review
Color
Unknown — pending review
Shape
Unknown — pending review
Form
TABLET
Labeler
Preferred Pharmaceuticals, Inc.
NDC
68788-8778 ↗ · 2026-06-18
384
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 400 mg/1
Imprint
384
Color
white
Shape
capsule
Form
TABLET, FILM COATED, EXTENDED RELEASE
Labeler
ACI Healthcare USA, Inc.
NDC
71093-139 ↗ · 2026-06-18
381
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 150 mg/1
Imprint
381
Color
white
Shape
capsule
Form
TABLET, FILM COATED, EXTENDED RELEASE
Labeler
ACI Healthcare USA, Inc.
NDC
71093-136 ↗ · 2026-06-18
382
Illustration based on reported characteristics. Appearance varies, identical-looking pills can contain completely different substances. Always test.
Strength
QUETIAPINE FUMARATE 200 mg/1
Imprint
382
Color
yellow
Shape
capsule
Form
TABLET, FILM COATED, EXTENDED RELEASE
Labeler
ACI Healthcare USA, Inc.
NDC
71093-137 ↗ · 2026-06-18

Dosage

Pending medical reviewer

Sources

← Back to the drug index